Skip to main content
. 2019 Jun 24;11(6):880. doi: 10.3390/cancers11060880

Figure 1.

Figure 1

p65BTK expression in specimen samples of stage III CRC. p65BTK Hematoxylin and Eosin (H&E) staining, original magnification 200×. (A) Tumor sample with 0% p65BTK expression. (B,C) Tumor samples with an intermediate percentage of expression. (D) Tumor sample with 100% p65BTK expression.